1. 赵茜 , 黄娟 , 吕楠 , 王学义 , 詹淑琴 , 胡永东 , 毛雪琴 , 王丽莉 , 吉恋英 , 程丽 , 张玲*.九味镇心颗粒治疗广泛性焦虑障碍的效果和安全性.中国医药.2022.17(7).1070-1073.核心期刊 |
2. 张文乐,杜芸,杨祥云,王恩聪,房捷欣,刘紫琦,吴珊茜,刘钦钦,胡永东*.Comparative efficacy of face-to-face and internet-based cognitive behavior therapy for generalized anxiety disorder: A meta-analysis of randomized controlled trial .Front Psychiatry.2022.13. .SCI |
3. 杜芸 、马可、冯若冰、房捷欣、丰雷、胡永东.艾司氯胺酮抗抑郁作用临床研究进展.北京医学.2022.44(2).153-156.核心期刊 |
4. 祖思、王刚、胡永东.Comparison of Residual Depressive Symptoms, Functioning, and Quality of Life Between Patients with Recurrent Depression and First Episode Depression After Acute Treatment in China.Neuropsychiatric Disease and Treatment.2021.17.3039-3051.SCI |
5. 房捷欣、肖乐、朱雪泉、王刚、冯若冰、胡永东*.氯胺酮治疗抑郁症抗自杀作用的初步研究.中国神经精神疾病杂志.2020.46(04).226-228.核心期刊 |
6. 冯若冰,肖乐,胡永东*.氯胺酮抗抑郁治疗临床研究进展.北京医学.2019.41(7).595-597.核心期刊 |
7. 房捷欣,肖乐,朱雪泉,王刚,冯若冰,胡永东*.单剂氯胺酮抗抑郁治疗对心率、血压和血氧饱和度的影响.中国神经精神疾病杂志.2019.45(6).361-364.核心期刊 |
8. Y.-D. Hu, Y.-T. Xiang*, J.-X. Fang, S. Zu, S. Sha, H. Shi, G. S. Ungvari, C. U. Correll, H. F. K. Chiu, Y. Xue, T.-F. Tian, A.-S. Wu, X. Ma and G. Wang*.Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.Psychological Medicine.2016.46(3).623-635.SCI |
9. 胡永东,房捷欣.氯胺酮的抗抑郁作用.中华精神科杂志.2015.48(1).53-54.核心期刊 |
10. 房捷欣,胡永东*.某综合医院心理科“医药分开”科室管理效果分析.中国病案.2015.16(10).44-45.核心期刊 |